EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sequential Targeting Chondroitin Sulfate‐Bilirubin Nanomedicine Attenuates Osteoarthritis via Reprogramming Lipid Metabolism in M1 Macrophages

Caifeng Deng, Yongbing Xiao, Xuan Zhao, Hui Li, Yuxiao Chen, Kelong Ai, Ting Jiang, Jie Wei, Xiaoyuan Chen, Guanghua Lei iD, Chao Zeng

Advanced Science · 2025-03 · 12 (9)

DOI: 10.1002/advs.202411911 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 10.01.2025. Verfasst von Caifeng Deng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China. Hauptthemen laut MEDLINE: Macrophages, Osteoarthritis, Chondroitin Sulfates, Lipid Metabolism. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 91 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation Regional Innovation and Development Joint Fund, Postdoctoral Innovative Talents Support Program, Project Program of National Clinical Research Center for Geriatric Disorders.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The infiltration and excessive polarization of M1 macrophages contribute to the induction and persistence of low‐grade inflammation in joint‐related degenerative diseases such as osteoarthritis (OA). The lipid metabolism dysregulation promotes M1 macrophage polarization by coordinating the compensatory pathways of the inflammatory and oxidative stress responses. Here, a self‐assembling, licofelone‐loaded nanoparticle (termed LCF‐CSBN), comprising chondroitin sulfate and bilirubin joined by an ethylenediamine linker, is developed to selectively reprogram lipid metabolism in macrophage activation. LCF‐CSBN is internalized by M1 macrophages via CD44‐mediated endocytosis and targets the Golgi apparatus accompanied with the reactive oxygen species‐responsive release of licofelone (LCF, dual inhibitor of arachidonic acid metabolism). LCF‐CSBN effectively promotes M1 to M2 macrophage transition by reprogramming the Golgi apparatus‐related sphingolipid metabolism and arachidonic acid metabolism. Intra‐articularly injected LCF‐CSBN retains in the joint for up to 28 days and accumulates into M1 macrophages. Moreover, LCF‐CSBN can effectively attenuate joint inflammation, oxidative stress, and cartilage degeneration in OA model rats. These findings indicate the promising potential of lipid‐metabolism‐reprogramming LCF‐CSBN in the targeted therapy of OA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MacrophagesOsteoarthritisChondroitin SulfatesLipid MetabolismNanomedicineAnimalsRatsNanoparticlesMaleDisease Models, AnimalRats, Sprague-DawleyMiceOxidative Stress

Stichwörter der Autor:innen

M1 macrophages repolarizationnanoparticlesosteoarthritisreprogramming of lipid metabolismtargeted therapy

Substanzen

Chondroitin Sulfates

Autor:innen und Institutionen

  • Department of Orthopaedics, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
  • Key Laboratory of Aging-related Bone and Joint Diseases Prevention and Treatment, Ministry of Education, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
  • Hunan Key Laboratory of Joint Degeneration and Injury, Xiangya Hospital, Central South University, Changsha, Hunan, 410008, China.
  • Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, 410008, China.
  • Departments of Diagnostic Radiology, Surgery, Chemical and Biomolecular Engineering and Biomedical Engineering, Yong Loo Lin School of Medicine and College of Design and Engineering, National University of Singapore, Si…
  • Clinical Imaging Research Centre, Centre for Translational Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, 117599, Singapore.

ORCID-Profile: Guanghua Lei

Förderung

  • National Natural Science Foundation Regional Innovation and Development Joint Fund
  • Postdoctoral Innovative Talents Support Program
  • Project Program of National Clinical Research Center for Geriatric Disorders
  • Key Research and Development Program of Hunan Province
  • Science and Technology Innovation Program of Hunan Province
  • Innovation-Driven Project of Central South University
  • Natural Science Foundation of Hunan Province
  • National Key Research and Development Project

Zitieren

APA

Deng, C., Xiao, Y., Zhao, X., Li, H., Chen, Y., Ai, K., Jiang, T., Wei, J., Chen, X., Lei, G., & Zeng, C. (2025). Sequential Targeting Chondroitin Sulfate‐Bilirubin Nanomedicine Attenuates Osteoarthritis via Reprogramming Lipid Metabolism in M1 Macrophages. Advanced Science, 12(9). https://doi.org/10.1002/advs.202411911

Vancouver

Deng C, Xiao Y, Zhao X, Li H, Chen Y, Ai K, et al. Sequential Targeting Chondroitin Sulfate‐Bilirubin Nanomedicine Attenuates Osteoarthritis via Reprogramming Lipid Metabolism in M1 Macrophages. Advanced Science. 2025;12(9). doi:10.1002/advs.202411911

BibTeX
@article{Deng2025,
  author = {Deng, Caifeng and Xiao, Yongbing and Zhao, Xuan and Li, Hui and Chen, Yuxiao and Ai, Kelong and Jiang, Ting and Wei, Jie and Chen, Xiaoyuan and Lei, Guanghua and Zeng, Chao},
  title = {Sequential Targeting Chondroitin Sulfate‐Bilirubin Nanomedicine Attenuates Osteoarthritis via Reprogramming Lipid Metabolism in M1 Macrophages},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {9},
  doi = {10.1002/advs.202411911}
}
Kostenlos starten →